The reckoning begins
Jury selection begins today in the federal criminal case against Elizabeth Holmes, the founder of the blood-testing tech start-up Theranos. Indicted in 2018, she faces a dozen counts of fraud and conspiracy to commit wire fraud for making false claims about Theranos’s blood tests and business prospects. She has pleaded not guilty. If convicted, Holmes, 37, faces up to 20 years in prison.
Opening arguments in the trial, which is expected to last three to four months, begin next week. At the heart of the proceedings, The Times’s Erin Griffith and Erin Woo write, is whether Holmes